International Healthway's affected subsidiaries resist receivers' actions
INTERNATIONAL Healthway Corporation (IHC) on Monday said that its receivers have tried to remove Jong Hee Sen and Lim Beng Choo as directors of the troubled company's affected subsidiaries, but these removals have been resisted.
On Aug 5, 2016, the group has received an Ex Parte Summon for Injunction application from the solicitors acting for the funds and fund managers (the plaintiffs) to restrain the group from removing the plaintiffs' nominated directors or appointing new directors in the affected subsidiaries.
The group is also restrained from giving instructions to the trustee of IHC Healthcare Reit, and to the trustee of Australia First Trust and IHC Australia Second Trust.
IHC, which is a healthcare services and facilities provider, said: "As the validity of the appointment of the receivers is being disputed, the group shall resist these actions from the plaintiffs vigorously. It should be noted that to date, the plaintiffs had not filed any claim against the group for amounts purportedly due to them."
Meanwhile, on the liquidation side of things, Crest Capital Asia Pte Ltd, as manager of the fund, has filed affidavits to object to these liquidations.
These liquidation applications are scheduled to be heard on Oct 31, 2016.
IHC said that it will continue to monitor the situation and update as necessary.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Latest Singapore 6-month T-bill offering cut-off yield of 3.74%
Suntec Reit Q1 DPU down 13% to S$0.01511 in absence of capital distribution
Nissan, Mazda roll out new models for China as they aim for comeback
South Korea readies new system to detect illegal short-selling
Axiata, Sinar Mas move closer to US$3.5 billion telco merger
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials